Persistent auditory hallucinations that are unresponsive to antipsychotic drugs

American Journal of Psychiatry

Volumn 163, Issue 7, 2006, Pages 1153-1159

  Nicolson, Stephen E ^a   Mayberg, Helen S ^a   Pennell, Page B ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; LAMOTRIGINE; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE; ANTICONVULSIVE AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ELECTROENCEPHALOGRAM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESTLESSNESS; SCHIZOPHRENIA; SEIZURE; TREATMENT OUTCOME; VISUAL HALLUCINATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; HALLUCINATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGICAL ASPECT; SCINTISCANNING; STATISTICS; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY;

ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TEMPORAL LOBE; TREATMENT OUTCOME;

EID: 85047696303     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.7.1153     Document Type: Article

References (50)

1. Andreasen NC: Linking mind and brain in the study of mental illness: a project for a scientific psychopathology. Science 1997; 275:1586-1593
2. Nayani TH, David AS: The auditory hallucination: a phenomenologic survey. Psychol Med 1996; 26:177-189
3. Tien AY: Distributions of auditory hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol 1991; 26:287-292
4. Salo R, Robertson LC: Perceptual disturbances in neurological and psychiatric populations, in Neuropsychiatry, 2nd ed. Edited by Schiffer RB, Rao SM, Fogel BS. Philadelphia, Lippincott Williams & Wilkins 2003, pp 481-502
5. Johnson FH: The Anatomy of Hallucinations. Chicago, Nelson-Hall, 1978, pp 1-40
6. Fricchione GL, Carbone L, Bennett WI: Psychotic disorder caused by a general medical condition, with delusions. Psychiatr Clin North Am 1995; 18:363-378
7. Hudziak JJ, Rettew DC: Bupropion, in Textbook of Psychopharmacology, 3rd ed. Edited by Schatzberg AF, Nemeroff CB. Arlington, Va, American Psychiatric Publishing, 2004, pp 327-339
8. Lautenschlager NT, Forstl H: Organic psychosis. Curr Psychiatry Rep 2001; 3:319-325
9. Small SA, Mayeux, R: Alzheimer disease and related dementias, in Merritt's Neurology, 11th ed. Edited by Rowland LP. Philadelphia, Lippincott Williams & Wilkins, 2003, pp 771-780
10. Aarland D, Larsen JP, Cummings JL, Laake K: Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease: a community-based study. Arch Neurol 1999; 56:595-602
11. Castle D, Wessely S, Der G, Murray RM: The incidence of operationally defined schizophrenia in Camberwell, 1965-84. Br J Psychiatry 1991; 159:790-794
12. Howard R, Rabins PV, Seeman MV, Jeste DV, the Late-Onset Schizophrenia Group: Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry 2000; 157:172-178
13. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, Andersen PK, Melbye M: Effects of family history and place and season of birth on the risk of schizophrenia. N Engl J Med 1999; 340:603-608
14. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593-602
15. Goldberg JF, Truman CJ: Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5:407-420
16. Kessler RC, Berglund P, Demler O, Jin R, Marikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593-602
17. Akiskal HS: Mood disorders: clinical features, in the Comprehensive Textbook of Psychiatry, 6th ed. Edited by Kaplan HI, Saddock BJ. Baltimore, Williams & Wilkins,1995, pp 1123-1152
18. Carroll BJ, Feinberg M, Smouse PE, Rawson SG, Greden JF: The Carroll Rating Scale for Depression I: development, reliability and validation. Br J Psychiatry 1981; 138:194-200
19. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
20. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for the grading of the cognitive state of patients for the clinician, J Psychiatr Res 1975; 12:189-198
21. Kanner AM: Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy. Epilepsia 2004; 45(suppl 2):22-27
22. Roberts GW, Done DJ, Bruton C, Crow TJ: A "mock up" of schizophrenia: temporal lobe epilepsy and schizophrenia-like psychosis. Biol Psychiatry 1990; 28:127-143
23. Slater E, Glithero E, Beard AW: The schizophrenia-like psychosis of epilepsy. Br J Psychiatry 1963; 109:95-150
24. Nathaniel-James DA, Brown RG, Maier M, Mellers J, Toone B, Ron MA: Cognitive abnormalities in schizophrenia and schizophrenia-like psychosis of epilepsy. J Neuropsychiatry Clin Neurosci 2004; 16:472-479
25. Bruton CJ, Stevens JR, Frith CD: Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology 1994; 44:34-42
26. Toone BK: The psychosis of epilepsy. J Neurol Neurosurg Psychiatry 2000; 69:1-3
27. Cavanaugh S, Glicenstein C: Intravenous lorazepam in the treatment of postictal psychosis. Psychosomatics 1993; 34:443-446
28. Tebartz EL, Baeumer D, Lemiux L, Woermann FG, Koepp M, Krishnamoorthy S, Thompson PJ, Ebert D, Trimble MR: Amygdala pathology in psychosis of epilepsy: a magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain 2002; 125:140-149
29. Gallhofer B, Trimble MR, Frackowiak R: A study of cerebral blood flow and metabolism in epileptic psychosis using positron emission tomography and oxygen. J Neurol Neurosurg Psychiatry 1985; 48:201-206
30. Marshall EJ, Syed GM, Fenwick PB, Lishman WA: A pilot study of schizophrenia-like psychosis in epilepsy using single photon emission computerized tomography. Br J Psychiatry 1993; 163:32-46
31. Roberts GW, Done DJ, Bruton C, Crow TJ: A "mock up" of schizophrenia: temporal lobe epilepsy and schizophrenia-like psychosis. Biol Psychiatry 1990; 28:127-143
32. Prendergast J, Spira P, Schnieden V: Post-ictal psychosis: an unusual clinical entity. Aust NZ J Psychiatry 1999; 33:433-435
33. Dunner DL, Zisook S, Billow AA, Batey SR, Johnston JA, Ascher JA: A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry 1998; 59:366-373
34. Wellbutrin XL: Prescribing Information. Research Triangle Park, NC, GlaxoSmithKline, 2005
35. Pisani F, Spina E, Oteri G: Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 1999; 40(suppl 10):S48-S56
36. Casey DE: Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57(suppl 11):40-45
37. Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U: EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol, and healthy subjects. Hum Psychopharmacol 2003; 18:641-646
38. Hauser WA, Annegers JF, Rocca WA: Descriptive epidemiology of epilepsy: contributions of population based studies from Rochester, MN. Mayo Clin Proc 1996; 71:576-586
39. Forsgren L: Epidemiology and prognosis of epilepsy and its treatment, in The Treatment of Epilepsy. Edited by Shorvon SD. Malden, Mass, Blackwell Scientific Science, 2004, pp 21-42
40. Lopez JLP, Longo J, Quintana F, Diez C, Berciano J: Late onset epileptic seizures. Acta Neurol Scand 1985; 72:380-384
41. Gilbert MR, Grossman SA: Incidence and nature of neurological problems in patients with solid tumors. J Neurol Neurosurg Psychiatry 1986; 81:951-954
42. Zaatreh MM, Firlik KS, Spencer DD, Spencer SS: Temporal lobe tumoral epilepsy. Neurology 2003; 61:636-641
43. Beaumont A, Whittle IR: The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wein) 2000; 142:1-15
44. Walczac TS, Jayakar P: Interictal EEG, in Epilepsy: A Comprehensive Textbook. Edited by Engel J, Pedley TA. Philadelphia, Lippincott-Raven, 1997, pp 831-848
45. Feinstein A: The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004; 49:157-163
46. Stevens JR: Psychosis and epilepsy. Ann Neurol 1983; 14:347-348
47. McNamara ME: Clinical neurology: psychiatric care of the medical patient in Medical Psychiatric Practice. Edited by Stoudemire A, Fogel BS. New York, Oxford University Press, 1983, pp 455-483
48. Hall RCW, Popkin MK, Devaul RA, Faillace LA, Stickney SK: Physical illness presenting as psychiatric disease. Arch Gen Psychiatry 1978; 35:1315-1320
49. Bain BK: CT scans of first break psychotic patients in good general health. Psychiatr Serv 1998; 49:234-235
50. Tucker GJ: Seizure disorders presenting with psychiatric symptomatology. Psychiatr Clin North Am 1998; 21:625-635